Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2008 3
2009 12
2010 2
2011 4
2012 3
2013 3
2014 1
2015 1
2016 2
2019 4
2020 6
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy.
Ergenç İ, Kani HT, Karabacak M, Cömert Özer E, Mehdiyev S, Jafarov F, Abacar KY, Kutluğ Ağaçkıran S, Sevik G, Aslan R, Alibaz Öner F, İnanç N, Atagündüz MP, Seçkin D, Özen Alahdab Y, Ergun T, Direskeneli H, Atuğ Ö. Ergenç İ, et al. Among authors: atug o. Turk J Gastroenterol. 2023 Mar;34(3):310. doi: 10.5152/tjg.2023.237002. Turk J Gastroenterol. 2023. PMID: 36919837 Free PMC article. No abstract available.
Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B.
Ergenç İ, Kani HT, Karabacak M, Cömert Özer E, Mehdiyev S, Jafarov F, Abacar KY, Kutluğ Ağaçkıran S, Sevik G, Aslan R, Alibaz Öner F, İnanç N, Atagündüz MP, Seçkin D, Özen Alahdab Y, Ergun T, Direskeneli H, Atuğ Ö. Ergenç İ, et al. Among authors: atug o. Turk J Gastroenterol. 2023 Feb;34(2):156-160. doi: 10.5152/tjg.2022.22196. Turk J Gastroenterol. 2023. PMID: 36445058 Free PMC article.
Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey.
Toruner M, Basaranoglu M, Atug O, Senturk O, Akyuz F, Cekic C, Over Hamzaoglu H, Tekin F, Sezgin O, Akpinar H, Celik AF, Tezel A, Gokturk HS, Kav T. Toruner M, et al. Among authors: atug o. Turk J Gastroenterol. 2022 May;33(5):406-413. doi: 10.5152/tjg.2022.21868. Turk J Gastroenterol. 2022. PMID: 35678798 Free article.
44 results